Evidence map›Paper›PMID 41750378›Full record

ArticleBiomolecules2026

Paulo Emilio Feuser, Ana Letícia Silva Coelho, Mariana de Melo Cardoso, Rahisa Scussel, Mírian Ívens Fagundes, Lariani Tamires Witt Titbohl, Isabela Karina Della-Flora, Ricardo Andrez Machado-de-Ávila, Paulo Cesar Lock Silveira, Debora de Oliveira and 1 more

Abstract read
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Paulo Emilio FeuserGraduate Program in Chemical Engineering, Department of Chemical Engineering and Food Engineering, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.ORCID 0000-0003-2372-8945
Ana Letícia Silva CoelhoGraduate Program in Chemical Engineering, Department of Chemical Engineering and Food Engineering, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.
Mariana de Melo CardosoGraduate Program in Health Science, Universidade do Extremo Sul Catarinense, Criciúma 88806-000, SC, Brazil.
Rahisa ScusselGraduate Program in Health Science, Universidade do Extremo Sul Catarinense, Criciúma 88806-000, SC, Brazil.ORCID 0000-0002-0931-604X
Mírian Ívens FagundesGraduate Program in Health Science, Universidade do Extremo Sul Catarinense, Criciúma 88806-000, SC, Brazil.ORCID 0000-0001-7451-2285
Lariani Tamires Witt TitbohlGraduate Program in Health Science, Universidade do Extremo Sul Catarinense, Criciúma 88806-000, SC, Brazil.
Isabela Karina Della-FloraGraduate Program in Chemical Engineering, Department of Chemical Engineering and Food Engineering, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.
Ricardo Andrez Machado-de-ÁvilaGraduate Program in Health Science, Universidade do Extremo Sul Catarinense, Criciúma 88806-000, SC, Brazil.ORCID 0000-0002-1303-0490
Paulo Cesar Lock SilveiraGraduate Program in Health Science, Universidade do Extremo Sul Catarinense, Criciúma 88806-000, SC, Brazil.
Debora de OliveiraGraduate Program in Chemical Engineering, Department of Chemical Engineering and Food Engineering, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.ORCID 0000-0001-7544-5045
Cristiano José de AndradeGraduate Program in Chemical Engineering, Department of Chemical Engineering and Food Engineering, Federal University of Santa Catarina, Florianópolis 88040-900, SC, Brazil.ORCID 0000-0003-0151-5172

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88882.316483/2019-01
6 · The paper itself

Abstract

Mannosylerythritol lipid-B (MEL-B) is a glycolipid whose biological properties have been widely investigated, especially in the skincare, food, and therapeutic fields. Despite this, few studies have addressed the toxicity of this glycolipid in vivo. Therefore, this work aimed to evaluate the in vivo oxidative stress induced by MEL-B in Swiss mice. MEL-B (50 and 150 mg/kg) was administered intraperitoneally at two exposure times, 24 and 72 h. Biochemical damage was quantified in the gastrocnemius, lungs, kidneys, heart, liver, and spleen. This study assessed the levels of reactive oxygen species, oxidative damage markers, antioxidant defenses, protein concentration, triglycerides, creatine kinase (CK-MB), and lactate dehydrogenase (LDH). DCF (2',7'-dichlorofluorescein), sulfhydryl, and SOD (superoxide dismutase) levels were used to assess oxidative damage and antioxidant defenses in cells. The results indicate that MEL-B did not trigger acute toxicity in the tested animals in a systemic context. Oxidative stress was observed in the liver samples, likely due to the metabolization of MEL-B. The levels of triglycerides and of CK-MB and LDH enzymes did not present any significant alteration (

Indexed as

BiosurfactantsGlycolipidsOxidative StressAnimalsAntioxidantsInjections, IntraperitonealLiverMaleMiceReactive Oxygen SpeciesAntioxidantsGlycolipidsmannosylerythritol lipidReactive Oxygen Speciesacute toxicitybiosurfactantglycolipidmannosylerythritol lipidsoxidative stress

Identifiers

PMID41750378
PMCPMC12938748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.